EIN 75-3065445

The Translational Genomics Research Institute

IRS 501(c) type
501(c)(3)
Num. employees
450
State
Year formed
2002
Most recent tax filings
2022-09-01
Description
The Translational Genomics Research Institute is focused on developing and translating microbial genomic discoveries into applications to advance human health in the areas of clinical medicine, public health and biodefense. The division seeks to advance our understanding of how changes in the microbiome contribute to health and disease. The division of integrated cancer genomics is utilizing state-of-the-art molecular technologies to uncover the multiple dimensions of molecular changes that occur in cancer, and integrate these datasets to capture a high-resolution image of the tumor molecule.
Total revenues
$47,789,496
2022
Total expenses
$74,504,945
2022
Total assets
$174,203,210
2022
Num. employees
450
2022

Program areas at The Translational Genomics Research Institute

June 26, 2022, marked The 20th anniversary of tgen's launch. What began with temporary laboratory and administrative space and a handful of employees has grown into an Institute with over 350 employees, multiple locations, hundreds of collaborations around The world, numerous groundbreaking studies, and nearly 20 spin-out companies. Today, our capacity to understand and leverage information from The human genome has never been greater. Tgen's ability to bring emerging new methods for interrogating a patient's genome into The clinical care of patients, The revolution in faster and lower-cost ways of cancer detection and The paths that reach The urban, The rural and more diverse populations, has never been greater. The sequence cost per-patient over The past decade has dropped 100-fold. This means tgen can sequence more patients, or sequence a patient again, to understand how their disease is progressing. As part of a national health system, this helps drive Research discovery, new methods for early detection, and more clinical trials. Sequencing accuracy has also improved 100-fold. This increased accuracy means tgen can detect cancer earlier - perhaps in its infancy - which leads to improved screening, post-treatment monitoring and biopsies with a low percentage of tumor present. This also allows us to expand genomic testing into more cancer types. We're also creating better reference genomes, especially in underserved populations. Having better references means a better understanding of which changes in The genome are significant and to which population.

Grants made by The Translational Genomics Research Institute

GranteeGrant descriptionAmount
City of Hope National Medical CenterProject Support$328,217

Who funds The Translational Genomics Research Institute

Grants from foundations and other nonprofits
GrantmakerDescriptionAmount
TGen FoundationFundraising for Tgen$11,063,484
City of Hope National Medical CenterSee Part Iv$587,246
The Narbha Institute (NARBHA)Program Support$550,000
...and 12 more grants received

Personnel at The Translational Genomics Research Institute

NameTitleCompensation
Robert StoneBD and Vice CHRM and Coh Chief Executive Officer and President$0
Teresa BurlesonChief Operating Officer$873,615
Manuel EstradaChief Financial Officer$352,079
James LoweyChief Information Officer / Vice President , Technology$275,730
Erin MasseyChief Development Officer Tgen Foundation
...and 13 more key personnel

Financials for The Translational Genomics Research Institute

RevenuesFYE 09/2022
Total grants, contributions, etc.$33,269,986
Program services$14,701,502
Investment income and dividends$634,120
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$-3,960,559
Net gain from sale of non-inventory assets$3,144,447
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$47,789,496

Form 990s for The Translational Genomics Research Institute

Fiscal year endingDate received by IRSFormPDF link
2022-092023-08-14990View PDF
2021-092022-08-08990View PDF
2020-092021-08-12990View PDF
2019-092020-10-08990View PDF
2018-092019-10-11990View PDF
...and 10 more Form 990s
Data update history
July 17, 2023
Posted financials
Added Form 990 for fiscal year 2021
July 11, 2023
Used new vendors
Identified 10 new vendors, including , , , , , , , , , and
May 7, 2023
Received grants
Identified 1 new grant, including a grant for $12,765,361 from TGen Foundation
May 7, 2023
Used new vendors
Identified 1 new vendor, including
August 13, 2022
Posted financials
Added Form 990 for fiscal year 2020
Nonprofit Types
Medical research organizationsResearch centersHeadquarter / parent organizationsCharities
Issues
Science and technologyHealthDiseases and disorders
Characteristics
Conducts researchLobbyingPartially liquidatedOperates internationallyReceives government fundingEndowed supportTax deductible donations
General information
Address
445 N 5th St 600
Phoenix, AZ 85004
Metro area
Phoenix-Mesa-Chandler, AZ
Website URL
tgen.org/ 
Phone
(602) 343-8400
Facebook page
helptgen 
Twitter profile
@tgen 
IRS details
EIN
75-3065445
Fiscal year end
September
Taxreturn type
Form 990
Year formed
2002
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
H90: Medical Specialty Research
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Central organization
Free account sign-up

Want updates when The Translational Genomics Research Institute has new information, or want to find more organizations like The Translational Genomics Research Institute?

Create free Cause IQ account